Skip to main content

High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype.

Publication ,  Journal Article
Jeong, Y-H; Park, Y; Bliden, KP; Tantry, US; Gurbel, PA
Published in: Heart
February 2012

Duke Scholars

Published In

Heart

DOI

EISSN

1468-201X

Publication Date

February 2012

Volume

98

Issue

4

Start / End Page

343

Location

England

Related Subject Headings

  • Ticlopidine
  • Thrombosis
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Male
  • Humans
  • Female
  • Cardiovascular System & Hematology
  • Atherosclerosis
  • Aspirin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jeong, Y.-H., Park, Y., Bliden, K. P., Tantry, U. S., & Gurbel, P. A. (2012). High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype. Heart, 98(4), 343. https://doi.org/10.1136/heartjnl-2011-301129
Jeong, Young-Hoon, Yongwhi Park, Kevin P. Bliden, Udaya S. Tantry, and Paul A. Gurbel. “High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype.Heart 98, no. 4 (February 2012): 343. https://doi.org/10.1136/heartjnl-2011-301129.
Jeong, Young-Hoon, et al. “High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype.Heart, vol. 98, no. 4, Feb. 2012, p. 343. Pubmed, doi:10.1136/heartjnl-2011-301129.

Published In

Heart

DOI

EISSN

1468-201X

Publication Date

February 2012

Volume

98

Issue

4

Start / End Page

343

Location

England

Related Subject Headings

  • Ticlopidine
  • Thrombosis
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Male
  • Humans
  • Female
  • Cardiovascular System & Hematology
  • Atherosclerosis
  • Aspirin